Anterior gradient protein 2 homolog (AGR2) significantly improves TJ structure in IBD patients and this protective mechanism is promoted by the suppression of NF-κB p65 mediated activation of the MLCK–MLC signaling pathway (56). This evidence concerns the gene MLC1 and irritable bowel syndrome.